11:09 AM EDT, 09/06/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Friday morning, declining 0.7% to 1,420.41 on the S&P Europe Select ADR Index, which is on pace to end the week down 3.7%.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and medical device maker EDAP TMS ( EDAP ) , which rose 5% and 3.8% respectively. They were followed by electronics company Koninklijke Philips ( PHG ) and pharmaceutical company Novo Nordisk ( NVO ) , which increased 1% and 0.9% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and semiconductor company Sequans Communications ( SQNS ) , which dropped 7.1% and 4.5% respectively. They were followed by biopharmaceutical companies Cellectis ( CLLS ) and Grifols ( GRFS ) , which lost 3.4% and 3.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana ( NCNA ) and pharmaceutical company GSK (GSK), which advanced 7.9% and 1.2% respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and tobacco company British American Tobacco ( BTI ) , which were up 1% and 0.6% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which fell 5.4% and 2.9% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and financial services company Barclays ( JJCTF ) , which were down 2.7% and 2.2% respectively.